Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.
Music for Blood Advances Talks is preformed by the Art Topilow Trio
All content for Blood Advances Talks is the property of Blood Advances Talks and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.
Music for Blood Advances Talks is preformed by the Art Topilow Trio
Concizumab: a novel anti-TFPI therapeutic for hemophilia
Blood Advances Talks
15 minutes
4 years ago
Concizumab: a novel anti-TFPI therapeutic for hemophilia
Amy Shapiro discusses the recent approval of concizumab for the treatment of patients with hemophilia. This novel subcutaneous homeostatic rebalancing agent has proven to be useful for the treatment of patients with hemophilia A and B, and we hope you find this talk to be useful to understand it.
Blood Advances Talks
Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.
Music for Blood Advances Talks is preformed by the Art Topilow Trio
